The role of 18F-FDG PET in minimizing variability in gross tumor volume delineation of soft tissue sarcomas

Radiother Oncol. 2024 May:194:110186. doi: 10.1016/j.radonc.2024.110186. Epub 2024 Feb 25.

Abstract

Background: Accurate gross tumor volume (GTV) delineation is a critical step in radiation therapy treatment planning. However, it is reader dependent and thus susceptible to intra- and inter-reader variability. GTV delineation of soft tissue sarcoma (STS) often relies on CT and MR images.

Purpose: This study investigates the potential role of 18F-FDG PET in reducing intra- and inter-reader variability thereby improving reproducibility of GTV delineation in STS, without incurring additional costs or radiation exposure.

Materials and methods: Three readers performed independent GTV delineation of 61 patients with STS using first CT and MR followed by CT, MR, and 18F-FDG PET images. Each reader performed a total of six delineation trials, three trials per imaging modality group. Dice Similarity Coefficient (DSC) score and Hausdorff distance (HD) were used to assess both intra- and inter-reader variability using generated simultaneous truth and performance level estimation (STAPLE) GTVs as ground truth. Statistical analysis was performed using a Wilcoxon signed-ranked test.

Results: There was a statistically significant decrease in both intra- and inter-reader variability in GTV delineation using CT, MR 18F-FDG PET images vs. CT and MR images. This was translated by an increase in the DSC score and a decrease in the HD for GTVs drawn from CT, MR and 18F-FDG PET images vs. GTVs drawn from CT and MR for all readers and across all three trials.

Conclusion: Incorporation of 18F-FDG PET into CT and MR images decreased intra- and inter-reader variability and subsequently increased reproducibility of GTV delineation in STS.

Keywords: GTV delineation; PET; Sarcoma; Variability.

MeSH terms

  • Adult
  • Aged
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Magnetic Resonance Imaging* / methods
  • Male
  • Middle Aged
  • Observer Variation
  • Positron-Emission Tomography* / methods
  • Radiopharmaceuticals
  • Radiotherapy Planning, Computer-Assisted / methods
  • Reproducibility of Results
  • Sarcoma* / diagnostic imaging
  • Sarcoma* / pathology
  • Sarcoma* / radiotherapy
  • Soft Tissue Neoplasms / diagnostic imaging
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / radiotherapy
  • Tomography, X-Ray Computed / methods
  • Tumor Burden*

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals